International Pharmaceutical Students’ Federation critical appraisal essay 2013- The challenge of individualised pharmaceutical care: the need for interprofessional education
Keywords:Education, Individualised, Interprofessional, Pharmacogenomics, Pharmaceutical, Telemedicine
In this essay, I will be examining multiple areas of individualised pharmaceutical care via a needle-like model, starting at the bio -molecular spectrum looking at the likes of pharmacogenomics and nanotechnology, to that of social aspects such as patient education and communication. In the bio-molecular end we will examine the implications of how the human genome project has opened up the avenues of individualised pharmaceutical care. In nanotechnology we examine the diverse clinical applications of nanotechnology and implications of using such technology.
We will also look at the use of interprofessional education and how it may affect the future of health work forces and work standards. Finally we will examine the effects of increasing the channels of dialogue between different health professions in order to produce a patient based team approach.
Ainsworth, R., Conboy, V., Norman, J. & Viner, N. (2004) Towards Multidisiplinary teamworking in musculoskeletal care: evolution of service. Musculoskeletal Care, 2(2), 113- 119.
GlaxosmithKlein (2012) Medsafe data sheet (online). Available at: http://www.medsafe. govt.nz/profs/datasheet/k/ Kivexatab.pdf. Accessed May 2013.
Huang, S., Temple, R., Throckmorton, D. & Lesko, L. (2007) Drug interaction studies: study design, data analysis, and implications for dosing and labelling public policy. Clinical pharmacology and Therapeutics, 81 (February), 298-304.
Leïpzig, R., Hyer, K., Ek, K., Wallenstein, S., Vezina, M., Fairchild, S., Cassel, C.K., Howe, J.L. (2002) Attitudes toward working on interdisciplinary Healthcare teams: A comparison by Discipline. Journal of American Geriatric Society, 50, 1141-1148.
Mao, Y., Zhang, Y. & Zhai, S. (2008) Mobile phone text messaging for pharmaceutical care in a hospital in China. Journal of Telemedicine and Telecare, 14, 410-414.
Pharmac (2013) Pharmac (online). Available at: www.pharmac.govt.nz/2013/05/01/ SA1192.pdf. Accessed May, 2013.
Ross, J.S., Schenkein, D.P., Kashala, O., Linette, G.P., Stec, J., Symmans, W.F., Pusztai, L. & Hortobagyi, G.N. (2004) Pharmacogenomics. Advances in Anatomy Pathology, 11(4), 211-220.
Sakamoto, J., Van de Ven, A.L., Godin, B., Blanco, E., Serda, R., Grattoni, A; Ziemys, A., Bouamrani, A., Hu, T., Ranganathan, S.I., De Rosa, E., Martinez, J.O., Smid, C.A., Buchanan, R.M., Lee, S., Srinivasan, S., Landry, M., Meyn, A., Taschiotti, E., Liu, X., Decuzzi, P. & Ferrari, M. (2010) Enabling individualised therapy through nanotechnology. Pharmacological Research, 62, 57-89.
Teutsch, C., 2003. Patient-doctor communication. Medical Clinics of North America, 87(5), 1115-1145.
Verbeek, R.K. (2008) Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. European Journal of Pharmacology, 64, 1147-1161.
Vogel, F. (1959) Moderne Probleme der Humangenetik. Ergeb Inn Med Kinderheikd, 12, 52-125.
Woods, D. (2013) New Zealand Formulary (online) Available at:www.nzf.org.nz. Accessed 1st May, 2013.
Wootton, R. (2012) Twenty years of Telemedicine in chronic disease management- an evidence synthesis. Journal of Telemedicine and Telecare, 18, 211-220.